Brincidofovir inhibits polyomavirus infection in vivo .

Arrienne B ButicZoe E KatzGe JinKoji FukushimaMasatoshi HazamaAron E Lukacher Matthew D Lauver

Published in: mBio (2024)

using mouse polyomavirus. We show that the drug is well-tolerated in mice, reduces infectious viral titers, and limits viral pathology, indicating the potential of brincidofovir as an anti-polyomavirus therapeutic.

Keyphrases

sars cov
emergency department
type diabetes
human health
risk assessment
adipose tissue
drug induced
adverse drug
climate change
skeletal muscle
wild type